Checkpoint Therapeutics

+$0.08 (+6.02%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CKPT and other ETFs, options, and stocks.

About CKPT

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.

CEO
James F. Oliviero
Employees
14
Headquarters
Waltham, Massachusetts
Founded
2014

CKPT Key Statistics

Market cap
128.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
428.10K
High today
$1.45
Low today
$1.32
Open price
$1.34
Volume
308.94K
52 Week high
$4.64
52 Week low
$0.96

CKPT Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure